DCF — STANISLAUS SURGICAL
Enterprise Value: $-69.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-69.4M
Enterprise Value
$-21.3M
PV of Cash Flows
$-48.0M
PV of Terminal Value
$-77.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $25.5M | $-4.7M | -18.0% | $-5.7M | $-5.2M |
| Year 2 | $26.2M | $-4.5M | -17.0% | $-5.6M | $-4.7M |
| Year 3 | $27.0M | $-4.4M | -16.0% | $-5.5M | $-4.2M |
| Year 4 | $27.8M | $-4.4M | -16.0% | $-5.6M | $-3.8M |
| Year 5 | $28.7M | $-4.4M | -16.0% | $-5.7M | $-3.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-69.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$24.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18761578825552563
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5